Lenalidomide in Combination With R-CHOP Produces High Response Rates and Progression-Free Survival in New, Untreated Diffuse Large B Cell Lymphoma Transformed From Follicular Lymphoma: Results From the Phase 2 MC078E Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.